#PHLO DIGITAL PHARMACY SERIES#

These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. The cookie is used to store the user consent for the cookies in the category 'Performance'.Īnalytical cookies are used to understand how visitors interact with the website. This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category 'Necessary'.

The cookie is used to remember the user consent for the cookies under the category 'Analytics'. This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category 'Advertisement'. If this cookie does not exist when HubSpot manages cookies, it is considered a new session. According to their documentation, whenever HubSpot changes the session cookie, this cookie is also set to determine if the visitor has restarted their browser. It does not correspond to any user ID in the web application and does not store any personally identifiable information. The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly. “With Scottish Enterprise investment, the company can scale up operations and expand its services into new markets.” “Phlo is a fantastic example of a growing innovative company that is helping patients and healthcare providers through its technology. Kerry Sharp, Director of Entrepreneurship and Investment at Scottish Enterprise, said: “Phlo’s dedication to building innovative digital solutions that put patients and clinicians at the heart of what they do is key to driving positive change in the sector, empowering patients and healthcare providers.” “Phlo’s drive and determination to improve patient access and healthcare outcomes at this pivotal moment for the pharmacy sector is impressive. Mark Bamforth, Founder of Thairm Bio, said: Phlo’s second product, Phlo Connect, provides pharmacy infrastructure that enables healthtech companies and private healthcare providers to offer a complete digital pharmacy service.Įxisting partners include Babylon, Leva Clinic, SkinDoc, Syrona Health and The Dermatology Partnership. More than 110,000 orders have been delivered since the platform’s launch in 2020. Phlo’s Digital Pharmacy offers a same-day NHS and private prescription delivery service to patients in Birmingham and London, and is set to launch in Manchester in 2023. “We have a very busy roadmap ahead and some incredibly exciting opportunities to take advantage of in 2023 and beyond.” “I would like to thank our existing and new investors for supporting Phlo’s mission as we enter into our next stage of growth. Nadeem Sarwar, Founder and CEO of Phlo, said: The round was led by Thairm Bio with support from Scottish Enterprise and a number of other high-profile angel investors.

#PHLO DIGITAL PHARMACY SERIES#

The Series A round – a combination of equity investment and the conversion of existing loan notes – follows the £2 million raised by Phlo in 2020 in the third largest recorded healthtech Crowdfunding campaign in Europe. The funds will be used to expand the reach of the Phlo Digital Pharmacy same-day medication delivery service and to scale its digital infrastructure platform for healthcare providers. UK digital pharmacy company Phlo has closed a £10m Series A round.

Phlo digital pharmacy